MGC Navigates Regulatory Uncertainty With Cannabis Skin Care
This article was originally published in The Rose Sheet
Executive Summary
US regulations concerning use of cannabinoid CBD in consumer products are complex and hazily defined, representing an additional set of challenges for companies launching CBD-based skin care to an already heavily regulated market. MGC Derma does not expect FDA to come down on its CBD use per se, but the firm's specific product claims could still be subject to scrutiny.
You may also be interested in...
Chilyo Plants CBD Skin Care To Soothe Inflammation From 'Environmental Stress'
Actor and martial arts enthusiast Shedrack Anderson co-founded San Francisco firm Chilyo LP to develop "Environmental Response Skincare" products to repair signs of premature aging with an approach targeting "daily stressors of an uncertain, ever-changing environment." Four-product line launched Feb. 5 comprises Facial Elixir Mist, Face & Neck Crème, Total Eye & Lobe Serum and Muscle Balm.
Lauder/Origins' Hello, Calm Mask: Gateway To Bigger Cannabis Skin-Care Play?
The firm hasn’t been swept up in CBD mania, but its new Origins Hello, Calm mask features hemp seed oil “renowned for helping treat skin concerns like dryness and visible irritation." The $28 product is available now at Sephora.com and Origins' website, with a wider rollout planned for October.
FDA Warns Reviva Labs For Collagen-Building, Anti-Inflammatory Claims
FDA cites Reviva for unapproved drug claims on eight of its products marketed as cosmetics. Included among targeted claims are familiar statements about collagen production, inflammation reduction and other benefits the agency views as structure/function effects. A number of the claims onceivably could be allowed under the revised "cosmetic" definition proposed by the Cosmetic Modernization Amendments of 2015.